| ||
| Czech Holocaust writer Arnost Lustig dies at 84 Variety By Will Tizard Celebrated Czech scribe and Holocaust survivor Arnost Lustig died of lung cancer Feb. 26, leaving behind a legacy of novels, many adapted for the screen, including "Dita Sax," "A Prayer for Katerina Horovitzova" and "Darkness Casts No ... See all stories on this topic » | ||
| FDA Grants Genentech a Hearing on Avastin's Use for Metastatic Breast Cancer ... Media Newswire (press release) In the non-small cell lung cancer trial, the most common life-threatening to fatal side effects that increased by two percent or more in people who received Avastin vs. those in the comparison group were reduced white blood cell counts ( 27 percent vs. ... See all stories on this topic » |
| ||
| Study shows chemoradiotherapy prior to surgery improves survival ... T4 non-small lung cancer who underwent chemotherapy before surgery had more than three times the survival rate than patients who only underwent surgery. www.physorg.com/.../2011-02-chemoradiotherapy-prior-surg... | ||
| I Was Also Previously Ignorant Concerning These Lung Cancer Stages ... A hard information for non-small mobile lung cancer survival by stage according to a 5-year survival charge: Stage 1 will be 47%, Stage The second will be ... cancerminus.com/.../i-was-also-previously-ignorant-concernin... | ||
| Lung cancer survival rate depends on the severity of the disease ... Lung cancer survival rate depends on the severity of the disease stage. Credit: Wikimedia article: Lung Cancer Survival Rate Information ... www.suite101.com/view_image_articles.cfm/2934414 | ||
| Novel methods for improved breast cancer survival - Cancer Health Novel methods for improved breast cancer survival A quarter of all women who suffer from breast cancer are at risk of metastasis a recurrence of the cancer. www.newhealthidea.com/.../novel-methods-for-improved-brea... |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment